The global Influenza Therapeutics market size is projected to reach US$ 9521.1 million by 2027, from US$ 6644.2 million in 2020, at a CAGR of 4.8% during 2021-2027. Influenza, commonly known as the flu, is an infectious disease caused by an influenza virus.